The staging of prostate cancer is based on the integration of the Tumor-Node-Metastasis (TNM) staging system, grade group derived from Gleason scores (GS) according to the International Society of Urological Pathology (ISUP) 2014 consensus guidelines, and prostate-specific antigen (PSA) level [2,3]. Here, KLK3 is linked to neoplasm.